Physician profile
Alan Job
NPI 1770080475
$61,167.20
in general payments reported to CMS, 2019-2025
12 companies · $3,742 in 2025
The $3,742 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53K · 2024: $3,956 · 2025: $3,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Travel and Lodging: $6,093 · Food and Beverage: $4,699 · Education: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Travel and Lodging | $6,093.05 |
| Food and Beverage | $4,699.49 |
| Education | $374.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $51,345.84 | 2023-2025 | Cd Horizon Spinal System, O-Arm, Unid_pass |
| Spineart USA INC | $5,414.92 | 2023-2025 | Perla C, Juliet Ll |
| Stryker Corporation | $2,581.11 | 2024-2025 | Cascadia Interbody System, Pangea, N/A |
| Synthes Gmbh | $818.54 | 2023 | |
| Orthofix Medical, INC. | $232.67 | 2024 | Firebird Nxg, Cervical-Stim |
| Cerapedics INC. | $202.20 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Becton, Dickinson and Company | $182.57 | 2025 | Channel Drain |
| Si-Bone, INC. | $173.12 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $123.12 | 2025 | |
| Baxter Healthcare | $47.51 | 2025 | Floseal |
| Depuy Synthes Sales INC. | $24.20 | 2025 | Velys |
| Ethicon US, LLC | $21.40 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Job listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.